A citation-based method for searching scientific literature

Jeffrey G Gross, Adam R Glassman, Lee M Jampol, Seidu Inusah, Lloyd Paul Aiello, Andrew N Antoszyk, Carl W Baker, Brian B Berger, Neil M Bressler, David Browning, Michael J Elman, Frederick L Ferris, Scott M Friedman, Dennis M Marcus, Michele Melia, Cynthia R Stockdale, Jennifer K Sun, Roy W Beck. JAMA 2015
Times Cited: 397







List of co-cited articles
634 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G Gross, Adam R Glassman, Danni Liu, Jennifer K Sun, Andrew N Antoszyk, Carl W Baker, Neil M Bressler, Michael J Elman, Frederick L Ferris, Thomas W Gardner,[...]. JAMA Ophthalmol 2018
156
33

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Quan Dong Nguyen, David M Brown, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Andrea Gibson, Judy Sy, Amy Chen Rundle, J Jill Hopkins,[...]. Ophthalmology 2012
27

Global prevalence and major risk factors of diabetic retinopathy.
Joanne W Y Yau, Sophie L Rogers, Ryo Kawasaki, Ecosse L Lamoureux, Jonathan W Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M Dekker, Astrid Fletcher, Jakob Grauslund,[...]. Diabetes Care 2012
25

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Lloyd Paul Aiello, Andrew N Antoszyk, Bambi Arnold-Bush, Carl W Baker, Neil M Bressler, David J Browning,[...]. N Engl J Med 2015
883
24

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Neil M Bressler, Susan B Bressler, Alexander J Brucker, Frederick L Ferris, G Robert Hampton, Chirag Jhaveri,[...]. Ophthalmology 2016
472
20

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Michael J Elman, Lloyd Paul Aiello, Roy W Beck, Neil M Bressler, Susan B Bressler, Allison R Edwards, Frederick L Ferris, Scott M Friedman, Adam R Glassman, Kellee M Miller,[...]. Ophthalmology 2010
926
17

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
Paul Mitchell, Francesco Bandello, Ursula Schmidt-Erfurth, Gabriele E Lang, Pascale Massin, Reinier O Schlingemann, Florian Sutter, Christian Simader, Gabriela Burian, Ortrud Gerstner,[...]. Ophthalmology 2011
883
15


Long-term effects of ranibizumab on diabetic retinopathy severity and progression.
Michael S Ip, Amitha Domalpally, J Jill Hopkins, Pamela Wong, Jason S Ehrlich. Arch Ophthalmol 2012
171
14

Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Jeffrey S Heier, Jean-François Korobelnik, David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Edoardo Midena, David S Boyer, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2016
192
14


Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
L P Aiello, R L Avery, P G Arrigg, B A Keyt, H D Jampel, S T Shah, L R Pasquale, H Thieme, M A Iwamoto, J E Park. N Engl J Med 1994
13

Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.
Tien Y Wong, Jennifer Sun, Ryo Kawasaki, Paisan Ruamviboonsuk, Neeru Gupta, Van Charles Lansingh, Mauricio Maia, Wanjiku Mathenge, Sunil Moreker, Mahi M K Muqit,[...]. Ophthalmology 2018
204
13

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.
David M Brown, Quan Dong Nguyen, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Patricio G Schlottmann, Amy Chen Rundle, Jiameng Zhang, Roman G Rubio,[...]. Ophthalmology 2013
540
13

Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.
Anthony Obeid, Daniel Su, Samir N Patel, Joshua H Uhr, Durga Borkar, Xinxiao Gao, Mitchell S Fineman, Carl D Regillo, Joseph I Maguire, Sunir J Garg,[...]. Ophthalmology 2019
53
22

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.
C P Wilkinson, Frederick L Ferris, Ronald E Klein, Paul P Lee, Carl David Agardh, Matthew Davis, Diana Dills, Anselm Kampik, R Pararajasegaram, Juan T Verdaguer. Ophthalmology 2003
11

Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Frank G Holz, David S Boyer, Edoardo Midena, Jeffrey S Heier, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2015
303
11

Intravitreal aflibercept for diabetic macular edema.
Jean-François Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, David S Boyer, Frank G Holz, Jeffrey S Heier, Edoardo Midena, Peter K Kaiser, Hiroko Terasaki, Dennis M Marcus,[...]. Ophthalmology 2014
465
11

Diabetic retinopathy.
Ning Cheung, Paul Mitchell, Tien Yin Wong. Lancet 2010
11


Diabetic retinopathy.
David A Antonetti, Ronald Klein, Thomas W Gardner. N Engl J Med 2012
988
10

Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti-VEGF Injections.
Anthony Obeid, Xinxiao Gao, Ferhina S Ali, Katherine E Talcott, Christopher M Aderman, Leslie Hyman, Allen C Ho, Jason Hsu. Ophthalmology 2018
53
16

The progress in understanding and treatment of diabetic retinopathy.
Alan W Stitt, Timothy M Curtis, Mei Chen, Reinhold J Medina, Gareth J McKay, Alicia Jenkins, Thomas A Gardiner, Timothy J Lyons, Hans-Peter Hammes, Rafael Simó,[...]. Prog Retin Eye Res 2016
395
9

Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
David S Boyer, Young Hee Yoon, Rubens Belfort, Francesco Bandello, Raj K Maturi, Albert J Augustin, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M Whitcup. Ophthalmology 2014
609
9

Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA).
Ursula Schmidt-Erfurth, Jose Garcia-Arumi, Francesco Bandello, Karina Berg, Usha Chakravarthy, Bianca S Gerendas, Jost Jonas, Michael Larsen, Ramin Tadayoni, Anat Loewenstein. Ophthalmologica 2017
245
9

Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy.
Jennifer K Sun, Adam R Glassman, Wesley T Beaulieu, Cynthia R Stockdale, Neil M Bressler, Christina Flaxel, Jeffrey G Gross, Michel Shami, Lee M Jampol. Ophthalmology 2019
43
20

Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial.
Raj K Maturi, Adam R Glassman, Kristin Josic, Andrew N Antoszyk, Barbara A Blodi, Lee M Jampol, Dennis M Marcus, Daniel F Martin, Michele Melia, Hani Salehi-Had,[...]. JAMA Ophthalmol 2021
21
42

Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
João Figueira, Emily Fletcher, Pascale Massin, Rufino Silva, Francesco Bandello, Edoardo Midena, Monica Varano, Sobha Sivaprasad, Haralabos Eleftheriadis, Geeta Menon,[...]. Ophthalmology 2018
50
16


Diabetic Retinopathy Preferred Practice Pattern®.
Christina J Flaxel, Ron A Adelman, Steven T Bailey, Amani Fawzi, Jennifer I Lim, G Atma Vemulakonda, Gui-Shuang Ying. Ophthalmology 2020
105
8


Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy.
Charles C Wykoff, David A Eichenbaum, Daniel B Roth, Lauren Hill, Anne E Fung, Zdenka Haskova. Ophthalmol Retina 2018
38
21

Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.
Elia J Duh, Jennifer K Sun, Alan W Stitt. JCI Insight 2017
329
8

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
Carl W Baker, Adam R Glassman, Wesley T Beaulieu, Andrew N Antoszyk, David J Browning, Kakarla V Chalam, Sandeep Grover, Lee M Jampol, Chirag D Jhaveri, Michele Melia,[...]. JAMA 2019
102
8


Diabetic Retinopathy: A Position Statement by the American Diabetes Association.
Sharon D Solomon, Emily Chew, Elia J Duh, Lucia Sobrin, Jennifer K Sun, Brian L VanderBeek, Charles C Wykoff, Thomas W Gardner. Diabetes Care 2017
316
8


Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies.
Paul Mitchell, Ian McAllister, Michael Larsen, Giovanni Staurenghi, Jean-Francois Korobelnik, David S Boyer, Diana V Do, David M Brown, Todd A Katz, Alyson Berliner,[...]. Ophthalmol Retina 2018
31
22

Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
Susan B Bressler, Danni Liu, Adam R Glassman, Barbara A Blodi, Alessandro A Castellarin, Lee M Jampol, Paul L Kaufman, Michele Melia, Harinderjit Singh, John A Wells. JAMA Ophthalmol 2017
86
8

Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.
Peter A Campochiaro, David M Brown, Andrew Pearson, Sanford Chen, David Boyer, Jose Ruiz-Moreno, Bruce Garretson, Amod Gupta, Seenu M Hariprasad, Clare Bailey,[...]. Ophthalmology 2012
304
7

Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy.
Lloyd Paul Aiello, Isoken Odia, Adam R Glassman, Michele Melia, Lee M Jampol, Neil M Bressler, Szilard Kiss, Paolo S Silva, Charles C Wykoff, Jennifer K Sun. JAMA Ophthalmol 2019
63
11

Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
Susan B Bressler, Wesley T Beaulieu, Adam R Glassman, Jeffrey G Gross, Lee M Jampol, Michele Melia, Mark A Peters, Michael E Rauser. Ophthalmology 2017
49
14

Effects of medical therapies on retinopathy progression in type 2 diabetes.
Emily Y Chew, Walter T Ambrosius, Matthew D Davis, Ronald P Danis, Sapna Gangaputra, Craig M Greven, Larry Hubbard, Barbara A Esser, James F Lovato, Letitia H Perdue,[...]. N Engl J Med 2010
765
7

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.
Michel Michaelides, Andrew Kaines, Robin D Hamilton, Samantha Fraser-Bell, Ranjan Rajendram, Fahd Quhill, Christopher J Boos, Wen Xing, Catherine Egan, Tunde Peto,[...]. Ophthalmology 2010
329
7

Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Michael J Elman, Neil M Bressler, Haijing Qin, Roy W Beck, Frederick L Ferris, Scott M Friedman, Adam R Glassman, Ingrid U Scott, Cynthia R Stockdale, Jennifer K Sun. Ophthalmology 2011
390
6

Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic Retinopathy.
Maureen G Maguire, Danni Liu, Adam R Glassman, Lee M Jampol, Chris A Johnson, Carl W Baker, Neil M Bressler, Thomas W Gardner, Dante Pieramici, Cynthia R Stockdale,[...]. JAMA Ophthalmol 2020
15
40


Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab.
Nicholas Papadopoulos, Joel Martin, Qin Ruan, Ashique Rafique, Michael P Rosconi, Ergang Shi, Erica A Pyles, George D Yancopoulos, Neil Stahl, Stanley J Wiegand. Angiogenesis 2012
639
6

Prevalence of and risk factors for diabetic macular edema in the United States.
Rohit Varma, Neil M Bressler, Quan V Doan, Michelle Gleeson, Mark Danese, Julie K Bower, Elizabeth Selvin, Chantal Dolan, Jennifer Fine, Shoshana Colman,[...]. JAMA Ophthalmol 2014
175
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.